Results 21 to 30 of about 23,073,058 (182)
Pharmacoeconomic analysis methods [PDF]
, 2022 In the last years, the growing interest of healthcare professionals, policy-makers, and other stakeholders in enlarging the role of economic evaluations was driven by several factors such as evidence-based healthcare culture, patient-centered actions ...
Tonin, Fernanda +2 more
core +1 more source
Overview of pharmacoeconomic modelling methods
, 2013 In the current climate of burgeoning health care costs, pharmacoeconomics is becoming increasingly important, but knowledge about pharmacoeconomic methods is limited among most clinicians.
Christopher Reid (23288479) +5 more
core +2 more sources
Pharmacoeconomic Analyses and Modeling
, 2019 Pharmacoeconomic analyses are increasingly used to help decision-makers assess the value of health interventions. This value assessment promotes the effective and affordable use of healthcare resources.
Thomas, Dixon +9 more
core +1 more source
A Systematic Review and Quality Assessment of Pharmacoeconomic Publications for China Compared to Internationally: Is the Quality of Evidence-base Sufficient for Health Technology Assessment? [PDF]
International Journal of Health Policy and ManagementBackground Pharmacoeconomic evaluations are becoming more important in China, and their research quality directly impacts government decisions, deserving extra attention.
Zhixin Fan +8 more
doaj +1 more source
Фармацевтичний журнал, 2022 Pulmonary arterial hypertension (PAH) is a rare, progressive disease with a poor prognosis in the absence of timely diagnosis and appropriate therapy. Despite significant advances in the treatment of PAH, many patients remain undiagnosed years after the ...
I. S. Datsenko
doaj +1 more source
Pharmacoeconomic Research and Clinical Trials: Concepts and Issues
, 1989 The purpose of this article is to provide an overview of the emerging discipline of pharmacoeconomics. Specific methodologies and terms are defined.
Raymond J. Townsend +3 more
core +1 more source
, 2014 Given financial constraints, drug manufacturers are required to provide pharmacoeconomic evaluations to demonstrate the value for money of their drug compared to current treatment when requesting reimbursement by publicly funded health care systems. This
Sabarre, Kelley-Anne
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Antimicrobial stewardship (AMS) programs were introduced to promote the judicious use of antimicrobials and to combat antimicrobial resistance. Quantifying antibiotic consumption is an important part of AMS initiatives to achieve these objectives.
Marjan Kandimahforoujaki +3 more
wiley +1 more source
Pharmacoeconomic evaluation and its application in clinical guideline development [PDF]
, 2018 Pharmacoeconomic evaluation is an analysis technique that combines data on both costs and health outcomes to allow clinical decision makers to assess the cost effectiveness of pharmaceutical products and services.
Dawoud, Dalia M
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.With multiple disease‐modifying therapies now available, treatment switching has become an important clinical consideration in the management of spinal muscular atrophy (SMA). While some switches are prompted by suboptimal clinical response, more commonly they are driven by treatment burden, convenience, or adverse events.
Andrej Belančić +4 more
wiley +1 more source